Showing results (211-220 of 221) with videos related to

Sort By:
Pageof 23
British Journal of Pharmacology|January 28, 2021
A conserved arginine with non-conserved function is a key determinant of agonist selectivity in α7 nicotinic ACh receptorsTeresa Minguez-Viñas, Beatriz E Nielsen, Deborah K Shoemark, et al.
Insect Biochemistry and Molecular Biology|March 27, 2001
[3H]-Methyllycaconitine: a high affinity radioligand that labels invertebrate nicotinic acetylcholine receptorsR J Lind, D J Hardick, I S Blagbrough, et al.
Journal of the American Chemical Society|December 7, 2019
A General Mechanism for Signal Propagation in the Nicotinic Acetylcholine Receptor FamilyAna Sofia F Oliveira, Christopher J Edsall, Christopher J Woods, et al.
The American Journal of Pathology|July 9, 2018
Association of Elevated Urinary miR-126, miR-155, and miR-29b with Diabetic Kidney DiseaseCristina Beltrami, Kate Simpson, Mark Jesky, et al.
Science Advances|July 3, 2018
Sampling molecular conformations and dynamics in a multiuser virtual reality frameworkMichael O'Connor, Helen M Deeks, Edward Dawn, et al.
BMC Nephrology|October 25, 2023
UK Kidney Association Clinical Practice Guideline: Sodium-Glucose Co-transporter-2 (SGLT-2) Inhibition in Adults with Kidney Disease 2023 UPDATEAlistair J Roddick, Alexa Wonnacott, David Webb, et al.
British Journal of Pharmacology|March 10, 2018
Experimental design and analysis and their reporting II: updated and simplified guidance for authors and peer reviewersMichael J Curtis, Steve Alexander, Giuseppe Cirino, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 23, 1997
ABT-089 [2-methyl-3-(2-(S)-pyrrolidinylmethoxy)pyridine]: I. A potent and selective cholinergic channel modulator with neuroprotective propertiesJ P Sullivan, D Donnelly-Roberts, C A Briggs, et al.
Journal of Parkinson'S Disease|February 20, 2025
Improving recruitment and retention of people with Parkinson's disease to clinical studies: A scoping reviewRebecca Petty, Veena Agarwal, Jennifer Allison, et al.
Journal of Parkinson'S Disease|May 3, 2024
Patient and Public Involvement and Engagement in the Development of a Platform Clinical Trial for Parkinson's Disease: An Evaluation ProtocolMarie-Louise Zeissler, Nikul Bakshi, Michèle Bartlett, et al.
Pageof 23